ubmslatePT-logo-ubm

PT Mobile Logo

Search form

Topics:

Kenneth J. Bender, PharmD, MA

Kenneth J. Bender, PharmD, MA

Posts by Author

"Ladies and gentlemen of the jury," began the PAINWeek 2016 speaker, in mock trial defense of a physician for over-prescribing opioid meds.

A PAINWeek 2016 expert panel gave attendees behind-the-scenes insight into the process behind the CDC's final recommendations.

At PAINWeek 2016, a session on abuse-deterrent formulations underscored that this drug class will never be free from abuse potential.

A PAINWeek audience experienced behavioral Rx during a presentation on effective non-drug treatment for migraine.

This PAINWeek 2016 presentation focused on how to more deeply involve patients in their own pain management plan.

An overview of the largest study to examine persistent pulmonary hypertension in newborns (PPHN) exposed to antidepressants late in pregnancy.

esolla/Shutterstock.com

Progress in identifying and effectively treating first-episode schizophrenia was marked by the simultaneous publication of a report on a 6-year study and on the 10-year follow-up of a large-scale trial.

A recent meta-analysis supports evidence of the effectiveness of the fixed olanzapine/fluoxetine combination (Symbyax) in treating the depressive phase of bipolar disorder. Response was ranked higher, but with no more adverse effects, than with treatment with olanzapine alone.

In a new study, "as needed" use of an opioid antagonist for heightened alcohol craving appeared to reduce the number of heavy drinking days and total amount of alcohol consumed.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.